ferric ferricyanide has been researched along with Amyloid Neuropathy Type 1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chebil, S; Deslouis, C; Faure, M; Gamby, J; Haghiri-Gosnet, AM; Le Potier, I; Pallandre, A; Taverna, M; Tribollet, B | 1 |
1 other study(ies) available for ferric ferricyanide and Amyloid Neuropathy Type 1
Article | Year |
---|---|
Improved electrochemical detection of a transthyretin synthetic peptide in the nanomolar range with a two-electrode system integrated in a glass/PDMS microchip.
Topics: Amyloid; Amyloid Neuropathies, Familial; Calibration; Dimethylpolysiloxanes; Electrochemical Techniques; Equipment Design; Ferricyanides; Ferrocyanides; Glass; Humans; Limit of Detection; Materials Testing; Microchemistry; Microelectrodes; Microfluidic Analytical Techniques; Oxidation-Reduction; Peptide Fragments; Prealbumin; Printing, Three-Dimensional; Reproducibility of Results; Surface Properties | 2014 |